Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Riluzole.
Torque teno mini virus infection and multiple sclerosis.
Systematic localization of common disease-associated variation in regulatory DNA.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
No Help from Dalfampridine in MS-Related Optic Neuritis
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.
A case of septal panniculitis secondary to interferon treatment.
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Fat-soluble vitamins as disease modulators in multiple sclerosis.
The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
Neuroscience. Myelin--more than insulation.
Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors.
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia.
Pages
« first
‹ previous
…
186
187
188
189
190
191
192
193
194
…
next ›
last »